accountstop using materials * Shares fall 2 percent WASHINGTON, Oct 20 (Reuters) - Two video news releases for King Pharmaceuticals' (KG.N) pain drug Embeda left out a warning about the risk of a fatal overdose, U.S. regulators said in a letter released on...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to UPDATE 1-US FDA: King pain drug videos misleading
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
